Efficacy and safety of denosumab treatment for Korean patients with Stage 3b–4 chronic kidney disease and osteoporosis
Jin Taek Kim, You Mi Kim, Kyong Yeun Jung, Hoonsung Choi, So Young Lee, Hyo-Jeong Kim
Korean J Intern Med. 2024;39(1):148-159. Published online 2023 Dec 22 DOI: https://doi.org/10.3904/kjim.2023.292
Citations to this article as recorded by 
Optimizing osteoporosis management in CKD patients
Yong Wang, Wei Zhou
Nefrología.2025; 45(4): 344. CrossRef
Optimizing osteoporosis management in CKD patients
Yong Wang, Wei Zhou
Nefrología (English Edition).2025; 45(4): 344. CrossRef
The Conundrum of Medical Fracture Prevention in Chronic Kidney Disease—Summary of the Evidence and Pragmatic Clinical Guidance
Simeon Schietzel, Uyen Huynh-Do
Journal of Clinical Medicine.2025; 14(22): 8145. CrossRef
Effect of denosumab, an anti-osteoporosis drug, on vascular calcification: A meta-analysis
Di Wang, Tongqiang Liu, Jingkui Lu, Wei Xu
Medicine.2024; 103(37): e39642. CrossRef